Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Braskem SA ( (BAK) ) just unveiled an update.
On October 1, 2025, Braskem S.A. announced that the Administrative Council for Economic Defense (CADE) has approved the Concentration Act No. 08700.006808/2025-81, submitted by NSP Investimentos S.A. and Petroquímica Verde Fundo de Investimento em Participações. This approval, which was unanimous and without restrictions, marks a significant step in the ongoing negotiations between the involved parties. Braskem has committed to keeping the market informed of any further developments, highlighting the potential impact on its operations and strategic positioning within the industry.
The most recent analyst rating on (BAK) stock is a Sell with a $2.50 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.
Spark’s Take on BAK Stock
According to Spark, TipRanks’ AI Analyst, BAK is a Underperform.
Braskem SA’s overall stock score is heavily impacted by its poor financial performance, characterized by declining profitability and high leverage. Technical indicators suggest bearish momentum, and valuation metrics are unfavorable with a negative P/E ratio and no dividend yield.
To see Spark’s full report on BAK stock, click here.
More about Braskem SA
Braskem S.A. is a leading company in the petrochemical industry, primarily engaged in the production of thermoplastic resins. The company is headquartered in Brazil and is known for its strong market presence in the Americas, with a focus on sustainable development and innovation in chemical products.
Average Trading Volume: 1,109,105
Technical Sentiment Signal: Sell
Current Market Cap: $1.07B
See more data about BAK stock on TipRanks’ Stock Analysis page.